Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

CytoViva integrates hyperspectral imaging technology with nano- scale microscope system

CytoViva : 22 August, 2008  (New Product)
CytoViva has integrated new hyperspectral imaging technology (HSI) with its advanced nano- scale microscope system.
The combination of technologies enables scientists to make advances in a wide range of nano-medicine and nano-materials research initiatives.

Over the past three years, the CytoViva Nano-scale Microscope System has been adopted by many of the leading nano-technology research centres. This includes world-class research hospitals such as Johns Hopkins School of Medicine and MD Anderson Cancer Center, as well as, government laboratories within the FDA, NASA and NIH. This technology has received wide acclaim, including two R and D 100 awards and a Nano50 award.

Hyperspectral Imaging is an effective method for identifying the presence of materials and biologicals based on their spectral signature. By incorporating HSI with the CytoViva Nano-scale Microscope System, scientists can quantitatively confirm the presence of specific nano-scale materials. HSI has the ability to capture and report this spectral data within each individual pixel of an image.

A primary application for this technology includes research of nano-particles used as a targeted Drug delivery vehicle for treating cancer. With the CytoViva system, scientists can observe these nano-particles as they are absorbed by the cancer cells and quantitatively confirm this process through identification of the particle's spectral signature.

According to Chuck Ludwig, CytoViva president, 'The development of our hyperspectral imaging capability was driven by customer requirements to quantify images from their CytoViva Microscope system. Now these scientists will be able to create spectral signatures of nano-scale materials as they interact with biological or polymeric composites. In addition HSI can often quantify the presence of materials not easily observed, even when using our advanced optical Microscope system.'

The CytoViva HSI technology has its origins over the past two decades within the Department of Defense. Primarily used in aerial reconnaissance, HSI has been used extensively by the military to identify camouflaged materials.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo